PhytoMed Health are also active in the field of drug discovery of new ethical drugs and has, through its in-house Research & Development Division, developed a pipeline of six novel drug candidates in cancer, diabetics, Alzheimers, Cardiovascular disease and other chronic dieases.The Company has also developed a novel,  anti-cancer composition which is already being sold in the markets. The Company is now in the process of conducting human clinical trials of our patened products. In addition to its in-house R&D capability, the company also has long term collaborative research and development agreements with a number of eminent universities and research institutes in USA, Canada, Germany and France.